Clinical Trials Browser

NIH × Dasatinib × Tumor-Agnostic × Clear all

NCT01445509 2026-05-22

Dasatinib in Combination With Bevacizumab to Treat Advanced Solid Tumors

Phase 1 Completed

Neoplasms